Pompano Beach, FL, January 24, 2013 -- Cord Blood America Inc. (OTCQB: CBAI) stock climbed 3.85% to $0.0027. The 52 week trading range for the company is $0.00 - $0.04. The shares of the company plunged 92% in the last one year. The company is a holding company. CBAI is primarily an umbilical cord blood stem cell preservation company, with a particular focus on the acquisition of customers in need of family based products and services.
Will CBAI Move Higher After Today’s Sudden Selling Activities? Don’t Miss The Free Trend Analysis here http://csrnewsdaily.com/c2/?company=CBAI
Advanced Cell Technology, Inc. (OTCQB: ACTC) shares fell 3.07% to $0.0790. The company, on Jan. 17, announced that it has reached a settlement agreement with CAMOFI and CAMZHN Master LDC (collectively, the "Investors") resolving a lawsuit filed against ACT in the Supreme Court of New York relating to the conversion price of certain notes and the exercise price of certain warrants. The Investors claimed that the conversion price for the debentures and warrants they held should have been adjusted as a result of a transaction entered into between the Company's previous management and an investor in 2010.
How Should Investors Trade ACTC After The Recent Momentum, Find Out Here http://csrnewsdaily.com/c2/?company=ACTC
Active Health Foods, Inc. (OTCQB: AHFD) shares fell 11.11% to $0.0008 in the early hour. The company, early this month, announced that on December 30, 2012 the Board of Directors of Active Health Foods, Inc. entered into a definitive agreement with Manos Beverages, Inc. wherein Manos Beverages, Inc. will be acquired by Active Health Foods, Inc. in a stock exchange. The exchange for holders of record as of December 30, 2012 will be three Active Health Foods, Inc. common shares for each Manos Beverages, Inc. common share.
Get Free Special Trend Analysis On AHFD Here http://csrnewsdaily.com/c2/?company=AHFD
Generex Biotechnology Corporation (OTCQB: GNBT) shares jumped 5.13% to $0.0410 after the company revealed yesterday the submission of a dossier of the results of the Phase III trial of its Generex Oral-lyn seeking approval of the diabetic drug's marketing and commercial distribution in India. This approval has been initiated by the company's Indian licensee, Shreya Life Sciences Pvt Ltd, and the papers were submitted to the Drugs Controller General (India) (DCGI), Central Drugs Standard Control Organization, Director General of Health Services, Ministry of Health and Family Welfare, Government of India.
Get Free Special Trend Analysis On GNBT Here http://csrnewsdaily.com/c2/?company=GNBT
FBC Holding Inc (OTCQB: FBCD) shares is trading at $0.0001 in the morning hour. The 52 week trading range for the company is $0.00 - $0.01. The shares of the company plunged 97% in the last one year. FBCD is a development-stage company. During the fiscal year ended July 31, 2010 (fiscal 2010), the Company focused in three areas, branding (product placement) in television production and movies, and the sale of mini-choppers and the associated merchandise of the brand Beverly Hills Choppers, including clothing, accessories and parts.
Get Free Special Trend Analysis On FBCD Here http://csrnewsdaily.com/c2/?company=FBCD
Csrnewsdaily.com has a finger on the pulse of many sectors including renewable energy, oil, pharma, mining, finance, and healthcare. Our in depth research and analysis of NASDAQ, OTCBB, Pink Sheets, and NYSE has yielded considerable gains for our subscribers.
Our to-the-minute reports and alerts coupled with breaking news, analysis, investment strategies, and FREE subscription email services contribute to our role as one of the leading investor relations marketing firms.
The assembled information disseminated by Csrnewsdaily.com is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Csrnewsdaily.com does expect that investors will buy and sell securities based on information assembled and presented in phd-trading.com. PLEASE always do your own due diligence, and consult your financial advisor.
Pacific Dynasty Consultants Inc.
2637 E Atlantic Blvd #22611 Pompano Beach, FL 33062